To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
作者信息
Magoon Rohan, Suresh Varun
机构信息
Department of Anaesthesia, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital - Baba Kharak Singh Marg, New Delhi, India.
Department of Anesthesia and Intensive Care, Jaber Al Ahmad Al Sabah Hospital -Arabian Gulf, Kuwait.
出版信息
Crit Care Sci. 2023 Dec 22;35(3):335-336. doi: 10.5935/2965-2774.20230383-en. eCollection 2023.
Abstract
摘要
相似文献
1
To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.致：《重症新型冠状病毒肺炎与神经功能障碍——SARS-CoV-2与其他感染性病原体的直接对比分析》
Crit Care Sci. 2023 Dec 22;35(3):335-336. doi: 10.5935/2965-2774.20230383-en. eCollection 2023.
2
To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.致：《重症新型冠状病毒肺炎与神经功能障碍——严重急性呼吸综合征冠状病毒2与其他传染性病原体的直接对比分析》
Crit Care Sci. 2023 Dec 22;35(3):338-339. doi: 10.5935/2965-2774.20230104-en. eCollection 2023.
3
Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.回复：重症新型冠状病毒肺炎与神经功能障碍——严重急性呼吸综合征冠状病毒2与其他感染性病原体的直接对比分析
Crit Care Sci. 2023 Dec 22;35(3):340-341. doi: 10.5935/2965-2774.20230104resp-en. eCollection 2023.
4
Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.回复：重症新型冠状病毒肺炎与神经功能障碍——严重急性呼吸综合征冠状病毒2与其他感染性病原体的直接对比分析
Crit Care Sci. 2023 Dec 22;35(3):337. doi: 10.5935/2965-2774.20230383resp-en. eCollection 2023.
5
Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.危重症 COVID-19 与神经功能障碍 - SARS-CoV-2 与其他传染性病原体的直接比较分析。
Rev Bras Ter Intensiva. 2022 Nov 4;34(3):342-350. doi: 10.5935/0103-507X.20220229-pt. eCollection 2022.
6
To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.致：《重症新型冠状病毒肺炎与神经功能障碍——SARS-CoV-2与其他传染性病原体的直接对比分析》
Crit Care Sci. 2024 Jun 17;36:e20240291en. doi: 10.62675/2965-2774.20240291-en. eCollection 2024.
7
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.新型冠状病毒（CoV）在神经系统中的发病机制和新兴病原体 SARS-CoV-2 的证据：神经系统损伤和表现的综述。
J Mol Neurosci. 2021 Nov;71(11):2192-2209. doi: 10.1007/s12031-020-01767-6. Epub 2021 Jan 19.
8
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.与严重急性呼吸综合征冠状病毒2型及其他冠状病毒相关的神经学表现：给临床医生的一篇叙述性综述
Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16.
9
SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).SARS-CoV-2 感染神经系统：新型冠状病毒病（COVID-19）相关神经系统受累的文献综述。
Bosn J Basic Med Sci. 2020 Aug 3;20(3):283-292. doi: 10.17305/bjbms.2020.4860.
10
SARS-CoV-2 and the nervous system: current perspectives.SARS-CoV-2 与神经系统：当前的观点。
Arch Virol. 2023 Jun 1;168(6):171. doi: 10.1007/s00705-023-05801-x.
引用本文的文献
1
Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.回复：重症新型冠状病毒肺炎与神经功能障碍——严重急性呼吸综合征冠状病毒2与其他传染性病原体的直接对比分析
Crit Care Sci. 2024 Nov 11;36:e20240180en. doi: 10.62675/2965-2774.20240180-en. eCollection 2024.
2
To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.致：《重症新型冠状病毒肺炎与神经功能障碍——SARS-CoV-2与其他传染性病原体的直接对比分析》
Crit Care Sci. 2024 Jun 17;36:e20240291en. doi: 10.62675/2965-2774.20240291-en. eCollection 2024.
本文引用的文献
1
Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.危重症 COVID-19 与神经功能障碍 - SARS-CoV-2 与其他传染性病原体的直接比较分析。
Rev Bras Ter Intensiva. 2022 Nov 4;34(3):342-350. doi: 10.5935/0103-507X.20220229-pt. eCollection 2022.
2
Plasma fibrinogen: An important piece of the COVID-19 ICU delirium puzzle?血浆纤维蛋白原：是解开新冠重症监护病房谵妄谜团的重要一环？
Med Hypotheses. 2022 Nov;168:110953. doi: 10.1016/j.mehy.2022.110953. Epub 2022 Sep 21.
3
Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis.药物和非药物干预措施预防危重症患者谵妄的系统评价和网状 Meta 分析。
Intensive Care Med. 2021 Sep;47(9):943-960. doi: 10.1007/s00134-021-06490-3. Epub 2021 Aug 11.
4
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.新型冠状病毒肺炎（COVID-19）危重症患者谵妄的患病率及危险因素（COVID-D）：一项多中心队列研究
Lancet Respir Med. 2021 Mar;9(3):239-250. doi: 10.1016/S2213-2600(20)30552-X. Epub 2021 Jan 8.
5
Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials.苯二氮䓬类与非苯二氮䓬类药物在机械通气危重症成人患者中的镇静作用比较：一项随机试验的系统评价和荟萃分析。
Crit Care Med. 2013 Sep;41(9 Suppl 1):S30-8. doi: 10.1097/CCM.0b013e3182a16898.
Zotero 插件